Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...
"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...
Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.
What’s unique about GLP-1s—a.k.a. Ozempic, Monjauro, Wegovy, and Zepbound, among others—is that they target hormones, which ...
Lentils are full of fiber, which “slows down digestion,” once again reproducing the effect of the GLP-1 drugs, at a cost of ...
The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...